Dermatologically active sesquiterpene lactones in trichomes of Parthenium hysterophorus L. (Compositae)
Rodríguez, E.; Dillon, M.O.; Mabry, T.J.; Mitchell, J.C.; Towers, G.H.
Experientia 32(2): 236-238
1976
ISSN/ISBN: 0014-4754 PMID: 1269624 Document Number: 98253
Document emailed within 1 workday
Related Documents
Grabarczyk, H.; Drozdz, B.; Hladoń, B.; Wojciechowska, J. 1977: Sesquiterpene lactones. Part XV. new cytostatic active sesquiterpene lactone from herb of Anthemis nobilis L Polish Journal of Pharmacology and Pharmacy 29(4): 419-423Taye, T.; Gossmann, M.; Einhorn, G.; Büttner, C.; Metz, R.; Abate, D. 2002: The potential of pathogens as biological control of parthenium weed (Parthenium hysterophorus L.) in Ethiopia Mededelingen 67(3): 409-420
Tiwari, V.D.; Sohi, A.S.; Chopra, T.R. 1979: Allergic Contact Dermatitis Due to Parthenium Hysterophorus Indian Journal of Dermatology Venereology and Leprology 45(6): 392-400
Téllez-Martínez; Taboada, J.; González-Diddi, M. 1980: Cytotoxicity of some sesquiterpene lactones "in vitro" Archivos de Investigacion Medica 11(4): 435-443
Bialecki, M.; Bloszyk, E.; Drozdz, B.; Hladoń, B.; Szwemin, S. 1973: Sesquiterpene lactones. 8. Cytostatic activity of grosheimin Polish Journal of Pharmacology and Pharmacy 25(2): 195-199
Xu, G.; Liang, Q.; Gong, Z.; Yu, W.; He, S.; Xi, L. 2006: Antitumor activities of the four sesquiterpene lactones from Elephantopus scaber L Experimental Oncology 28(2): 106-109
Hladoń, B.; Chodera, A. 1975: Sesquiterpene lactones XVII. Cytostatic and pharmacological activity Archivum Immunologiae et Therapiae Experimentalis 23(6): 857-865
Barbetti, P.; Casinovi, C.G. 1981: Sesquiterpene lactones of pharmacological importance: structural and functional properties. II. Germacranolides Annali Dell'istituto Superiore di Sanita 17(2): 283-322
Kalodera, Z.; Pepeljnjak, S.; Petrak, T. 1996: The antimicrobial activity of Tanacetum parthenium extract Die Pharmazie 51(12): 995-996
McFadyen, R.E. 1995: Parthenium weed and human health in Queensland Australian Family Physician 24(8): 1455-1459
Roed-Petersen, J.; Thomsen, K. 1980: Azathioprin in the treatment of airborne contact dermatitis from compositae oleoresins and sensitivity to UVA Acta Dermato-Venereologica 60(3): 275-277
Thune, P.; Sandberg, M. 1987: Allergy to lichen and compositae compounds in perfumes. Investigations on the sensitizing, toxic and mutagenic potential Acta Dermato-Venereologica. Supplementum 134: 87-89
El Sawy, M.F.; Duncan, J.; Marshall, T.F.; Shehata, M.A.; Brown, N. 1984: The molluscicidal properties of Ambrosia maritima L. (Compositae). 2. Results from a field trial using dry plant material Tropenmedizin und Parasitologie 35(2): 100-104
Hausen, B.M. 1981: Occupational contact allergy to feverfew Tanacetum parthenium (L.) Schultz-Bip.; Asteraceae Dermatosen in Beruf und Umwelt. Occupation and Environment 29(1): 18-21
Rodríguez Santos, O.; Rodríguez Gavaldá, R.; Silva Pérez, R. 2001: Clinical diagnostic assay of allergic patients with pollen extract from Parthenium hysterophorous L Revista Alergia Mexico 48(2): 45-47
El Sawy, M.F.; Duncan, J.; Amer, S.; el Ruweini, H.; Brown, N.; Hills, M. 1987: The molluscicidal properties of Ambrosia maritima L. (Compositae). 3. a comparative field trial using dry and freshly-harvested plant material Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 38(2): 101-105
Xu, G.S.; Chen, X.Y.; Yu, D.Q. 1988: Rupestonic acid, a new sesquiterpene from Artemisia rupestris L Yao Xue Xue Bao 23(2): 122-125
el Sayed, K.A. 2001: A pseudoguaiane sesquiterpene xylopyranoside from Echinops hussoni Die Pharmazie 56(5): 415-417
Xie, Y.-y.; Li, Y.-x.; Sun, Y.-m.; Wang, Y.; Guo, M.-l. 2016: A new anti-hypoxia sesquiterpene from the rhizome of Petasites japonicas Yao Xue Xue Bao 51(8): 1285-1289
Mendes, G.L.; Santos, A.R.; Malheiros, A.; Filho, V.C.; Yunes, R.A.; Calixto, J.B. 2000: Assessment of mechanisms involved in antinociception caused by sesquiterpene polygodial Journal of Pharmacology and Experimental Therapeutics 292(1): 164-172